Moderate and High Disease Activity Predicts the Development of Carotid Plaque in Rheumatoid Arthritis Patients without Classic Cardiovascular Risk Factors: Six Years Follow-Up Study.

carotid plaque prospective study rheumatoid arthritis

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
27 Oct 2021
Historique:
received: 12 09 2021
revised: 24 10 2021
accepted: 25 10 2021
entrez: 13 11 2021
pubmed: 14 11 2021
medline: 14 11 2021
Statut: epublish

Résumé

Patients with rheumatoid arthritis (RA) have a higher incidence of subclinical atherosclerosis and cardiovascular (CV) disease. It is postulated that the appearance of accelerated atherosclerosis in these patients is a consequence of the inflammation present in the disease. In this study, we aim to determine if baseline disease activity in patients with RA predicts the future development of carotid plaque. A set of consecutive RA patients without a history of CV events, cancer or chronic kidney disease, who did not show carotid plaque in a carotid ultrasound assessment, were prospectively followed up for at least 5 years. At the time of recruitment, CV risk factors and disease-related data, including disease activity scores, were assessed. At the end of the follow-up, a carotid ultrasound was repeated and patients were divided into two groups; those who developed carotid plaque, and those who did not. A multivariable regression analysis was performed to define the predictors for the development of carotid plaque. One hundred and sixty patients with RA were followed up for an average of 6 ± 1 years. After this time, 66 (41%) of the patients had developed carotid plaque, and 94 (59%) did not. Patients with carotid plaque were significantly older (47 ± 13 vs. 55 ± 9 years,

Identifiants

pubmed: 34768495
pii: jcm10214975
doi: 10.3390/jcm10214975
pmc: PMC8585072
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI18/00043

Références

Ann Rheum Dis. 2015 Apr;74(4):668-74
pubmed: 24389293
Ann Rheum Dis. 2010 Nov;69(11):1920-5
pubmed: 20444756
Arthritis Rheum. 2007 Feb 15;57(1):125-32
pubmed: 17266100
Arthritis Rheum. 2001 Dec;44(12):2737-45
pubmed: 11762933
Arthritis Rheum. 2005 Sep;52(9):2625-36
pubmed: 16142705
Semin Arthritis Rheum. 2020 Dec;50(6):1333-1338
pubmed: 32416998
Autoimmun Rev. 2016 Nov;15(11):1013-1030
pubmed: 27490206
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
Best Pract Res Clin Rheumatol. 2016 Oct;30(5):851-869
pubmed: 27964792
Arthritis Care Res (Hoboken). 2011 Apr;63(4):522-9
pubmed: 20957658
Arthritis Rheum. 2008 Dec 15;59(12):1690-7
pubmed: 19035419
Ann Rheum Dis. 2015 Jun;74(6):998-1003
pubmed: 24458537
Cerebrovasc Dis. 2007;23(1):75-80
pubmed: 17108679
Arthritis Rheumatol. 2015 Jun;67(6):1449-55
pubmed: 25776112
Arthritis Rheum. 1995 Jan;38(1):44-8
pubmed: 7818570
J Rheumatol. 2005 Jul;32(7):1219-23
pubmed: 15996055
Ann Rheum Dis. 2014 Apr;73(4):722-7
pubmed: 23505241

Auteurs

Iván Ferraz-Amaro (I)

Division of Rheumatology, Hospital Universitario de Canarias, 38320 Tenerife, Spain.

Alfonso Corrales (A)

Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, 39011 Santander, Spain.
Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain.

Belén Atienza-Mateo (B)

Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain.

Nuria Vegas-Revenga (N)

Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain.

Diana Prieto-Peña (D)

Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain.

Ricardo Blanco (R)

Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain.

Miguel Á González-Gay (MÁ)

Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, 39011 Santander, Spain.
Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain.
Cardiovascular Pathophysiology and Genomics Research Unit, Faculty of Health Sciences, School of Physiology, University of the Witwatersrand, Johannesburg 2000, South Africa.

Classifications MeSH